Related Experiment Video
Updated: May 19, 2026

Analysis of β-Amyloid-induced Abnormalities on Fibrin Clot Structure by Spectroscopy and Scanning Electron Microscopy
Published on: November 30, 2018
Alzheimer Aβ peptide interactions with lipid membranes: fibrils, oligomers and polymorphic amyloid channels
Florentina Tofoleanu1, Nicolae-Viorel Buchete
1School of Physics, University College Dublin, Dublin, Ireland.
Abstract:
Fibrillar aggregates of misfolded amyloid proteins are involved in a variety of diseases such as Alzheimer disease (AD), type 2 diabetes, Parkinson, Huntington and prion-related diseases. In the case of AD amyloid β (Aβ) peptides, the toxicity of amyloid oligomers and larger fibrillar aggregates is related to perturbing the biological function of the adjacent cellular membrane. We used atomistic molecular dynamics (MD) simulations of Aβ 9-40 fibrillar oligomers modeled as protofilament segments, including lipid bilayers and explicit water molecules, to probe the first steps in the mechanism of Aβ-membrane interactions. Our study identified the electrostatic interaction between charged peptide residues and the lipid headgroups as the principal driving force that can modulate the further penetration of the C-termini of amyloid fibrils or fibrillar oligomers into the hydrophobic region of lipid membranes. These findings advance our understanding of the detailed molecular mechanisms and the effects related to Aβ-membrane interactions, and suggest a polymorphic structural character of amyloid ion channels embedded in lipid bilayers. While inter-peptide hydrogen bonds leading to the formation of β-strands may still play a stabilizing role in amyloid channel structures, these may also present a significant helical content in peptide regions (e.g., termini) that are subject to direct interactions with lipids rather than with neighboring Aβ peptides.
Insights
Amyloid aggregates, implicated in diseases like Alzheimer's, interact with cell membranes. Electrostatic forces drive amyloid-beta peptides into lipid bilayers, influencing membrane function and forming polymorphic ion channels.
Area of Science:
- Biochemistry
- Molecular Biology
- Computational Biophysics
Background:
- Fibrillar aggregates of misfolded amyloid proteins are linked to neurodegenerative and metabolic diseases.
- Amyloid beta (Aβ) peptides in Alzheimer disease (AD) exert toxicity by disrupting cellular membrane function.
- Understanding Aβ-membrane interactions is crucial for elucidating disease mechanisms.
Purpose of the Study:
- To investigate the initial molecular mechanisms of amyloid beta (Aβ) interactions with lipid membranes.
- To identify the driving forces behind Aβ peptide insertion into the hydrophobic core of lipid bilayers.
- To explore the structural characteristics of amyloid aggregates when embedded within cell membranes.
Main Methods:
- Atomistic molecular dynamics (MD) simulations were employed.
- Simulations included Aβ 9-40 fibrillar oligomers, lipid bilayers, and explicit water molecules.
- Analysis focused on the initial stages of Aβ-membrane association.
Main Results:
- Electrostatic interactions between charged peptide residues and lipid headgroups are the primary drivers of Aβ penetration into membranes.
- The C-termini of amyloid fibrils/oligomers can insert into the hydrophobic membrane region.
- Amyloid structures within lipid bilayers exhibit polymorphic characteristics, including helical content in lipid-interacting regions.
Conclusions:
- Aβ-membrane interactions are initiated and modulated by electrostatic forces.
- These interactions can lead to the formation of amyloid ion channels with diverse structures.
- The findings provide insights into the molecular basis of Aβ toxicity and membrane disruption in diseases like AD.
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Alzheimer Disease ll: Pathophysiology
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer Disease l: Introduction
Dementia l: Introduction

